Menghang Xia Selected Research

diglycidyl resorcinol ether

8/2011

Characterization of environmental chemicals with potential for DNA damage using isogenic DNA repair-deficient chicken DT40 cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Menghang Xia Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 08/2009
7	Infections 05/2022 - 05/2010
5	Hypoxia (Hypoxemia) 01/2018 - 09/2009
4	Cardiotoxicity 01/2022 - 01/2017
4	Inflammation (Inflammations) 01/2022 - 09/2009
3	COVID-19 05/2022 - 01/2021
3	Zika Virus Infection 01/2021 - 10/2016
3	Chordoma 01/2021 - 01/2013
2	Flavivirus Infections 12/2020 - 01/2018
2	Viremia 12/2020 - 08/2017
2	Neuroblastoma 01/2018 - 05/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2015
2	Colonic Neoplasms (Colon Cancer) 02/2016 - 01/2016
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2016 - 08/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 05/2010
2	Breast Neoplasms (Breast Cancer) 06/2014 - 05/2014
2	Long QT Syndrome 05/2011 - 11/2009
1	Triple Negative Breast Neoplasms 01/2022
1	Blast Crisis (Blast Phase) 01/2022
1	Leukemia 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Carcinogenesis 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 12/2021
1	Pain (Aches) 01/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	LEOPARD Syndrome (Syndrome, LEOPARD) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Obesity 01/2018
1	Animal Disease Models 12/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Fibrosarcoma 11/2016
1	Microcephaly 10/2016
1	Nervous System Diseases (Neurological Disorders) 05/2016
1	Glioma (Gliomas) 01/2016

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 12/2021 - 11/2009
5	Proteins (Proteins, Gene)FDA Link 05/2022 - 08/2009
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2009
3	Ether (Diethyl Ether)IBA 01/2022 - 11/2009
3	NF-kappa B (NF-kB)IBA 01/2022 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 11/2009
3	LuciferasesIBA 02/2016 - 05/2014
3	CytokinesIBA 01/2012 - 09/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2019
2	CateninsIBA 01/2022 - 12/2019
2	Biological ProductsIBA 01/2021 - 12/2016
2	Caspase 3 (Caspase-3)IBA 10/2016 - 05/2010
2	Investigational DrugsIBA 02/2016 - 07/2013
2	baicaleinIBA 01/2016 - 04/2012
2	Digoxin (Digitek)FDA LinkGeneric 07/2013 - 08/2009
2	Oxygen (Dioxygen)IBA 12/2009 - 11/2009
1	Angiotensin-Converting Enzyme 2IBA 05/2022
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	pyrvinium (Vankin)FDA Link 01/2022
1	Orphan Nuclear ReceptorsIBA 01/2022
1	ERRalpha Estrogen-Related ReceptorIBA 01/2022
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2021
1	PlatinumIBA 12/2021
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	CrizotinibIBA 01/2021
1	AfatinibIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	Methylene Blue (Methylthioninium Chloride)FDA Link 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	AMP-Activated Protein KinasesIBA 12/2019
1	ProdrugsIBA 10/2019
1	Food Additives (Food Additive)IBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	ifenprodilIBA 01/2018
1	1-dodecylpyridoxal (PLD)IBA 01/2018
1	EmetineIBA 01/2018
1	EnzymesIBA 01/2018
1	cephaelinIBA 01/2018
1	Erythrosine (Erythrosin)IBA 01/2018
1	temoporfinIBA 08/2017
1	Amplex RedIBA 05/2017
1	PotassiumIBA 01/2017
1	Kelch-Like ECH-Associated Protein 1IBA 11/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2016
1	Mitogen-Activated Protein KinasesIBA 02/2016
1	Niclosamide FDA Link 02/2016
1	Proteasome InhibitorsIBA 02/2016
1	trametinibIBA 02/2016
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2016
1	A-Form DNA (A-DNA)IBA 01/2016
1	undecaneIBA 01/2016
1	nanolucIBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2013